<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; head and neck cancer</title>
	<atom:link href="http://oralcancernews.org/wp/tag/head-and-neck-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Mon, 21 May 2012 12:57:26 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Stem cell sparing radiotherapy for head and neck cancer may avoid salivary gland damage</title>
		<link>http://oralcancernews.org/wp/stem-cell-sparing-radiotherapy-for-head-and-neck-cancer-may-avoid-salivary-gland-damage/</link>
		<comments>http://oralcancernews.org/wp/stem-cell-sparing-radiotherapy-for-head-and-neck-cancer-may-avoid-salivary-gland-damage/#comments</comments>
		<pubDate>Thu, 10 May 2012 16:41:29 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[European Society for Radiotherapy and Oncology]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[Ontario Cancer Institute]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[salivary gland]]></category>
		<category><![CDATA[stem cells]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=13022</guid>
		<description><![CDATA[Source: European Society for Radiotherapy and Oncology (ESTRO) Barcelona, Spain: Researchers believe they may have found a way to avoid damaging salivary glands during radiotherapy treatment for head and neck cancer – a discovery that could improve the quality of life of 500,000 patients a year worldwide with the disease. Presenting their findings to the 31st [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/stem-cell-sparing-radiotherapy-for-head-and-neck-cancer-may-avoid-salivary-gland-damage/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study: Oral cancers take financial toll</title>
		<link>http://oralcancernews.org/wp/the-cost-burden-of-oral-oral-pharyngeal-and-salivary-gland-cancers-in-three-groups-commercial-insurance-medicare-and-medicaid/</link>
		<comments>http://oralcancernews.org/wp/the-cost-burden-of-oral-oral-pharyngeal-and-salivary-gland-cancers-in-three-groups-commercial-insurance-medicare-and-medicaid/#comments</comments>
		<pubDate>Thu, 26 Apr 2012 18:52:43 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[OCF In The News]]></category>
		<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[Medicaid]]></category>
		<category><![CDATA[Medicare]]></category>
		<category><![CDATA[oral cavity]]></category>
		<category><![CDATA[oral pharyngeal]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[salivary gland cancer]]></category>
		<category><![CDATA[surgery]]></category>
		<category><![CDATA[The Oral Cancer Foundation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12913</guid>
		<description><![CDATA[Source: Dr.Biscuspid.com April 26, 2012 &#8212; The cost of treating individuals with oral, orapharyngeal, and salivary gland cancers is significant, particularly for patients who undergo all three forms of treatment, according to a new study by Delta Dental of Michigan&#8217;s Research and Data Institute. And for many that is only the beginning of the financial [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/the-cost-burden-of-oral-oral-pharyngeal-and-salivary-gland-cancers-in-three-groups-commercial-insurance-medicare-and-medicaid/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prognostic Significance of HPV Status in Oropharyngeal Cancer</title>
		<link>http://oralcancernews.org/wp/prognostic-significance-of-hpv-status-in-oropharyngeal-cancer/</link>
		<comments>http://oralcancernews.org/wp/prognostic-significance-of-hpv-status-in-oropharyngeal-cancer/#comments</comments>
		<pubDate>Wed, 18 Apr 2012 17:16:03 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[alcohol]]></category>
		<category><![CDATA[chemoradiation]]></category>
		<category><![CDATA[Dr. Maura Gillison]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV-positive cancer]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>
		<category><![CDATA[radiation therapy]]></category>
		<category><![CDATA[Radiation Therapy Oncology Group]]></category>
		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12852</guid>
		<description><![CDATA[OncologySTAT Editorial Team Dr. Maura Gillison is Professor of Medicine, Epidemiology, and Otolaryngology at Ohio State University in Columbus. OncologySTAT: The results of the Radiation Therapy Oncology Group (RTOG) 0129 trial showed that the human papillomavirus (HPV) is an independent prognostic factor in oropharyngeal cancer. Could you tell us about the rationale for this study? [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/prognostic-significance-of-hpv-status-in-oropharyngeal-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV DNA, E6?I-mRNA expression and p16(INK4A) immunohistochemistry in head and neck cancer &#8211; how valid is p16(INK4A) as surrogate marker?</title>
		<link>http://oralcancernews.org/wp/hpv-dna-e6i-mrna-expression-and-p16ink4a-immunohistochemistry-in-head-and-neck-cancer-how-valid-is-p16ink4a-as-surrogate-marker/</link>
		<comments>http://oralcancernews.org/wp/hpv-dna-e6i-mrna-expression-and-p16ink4a-immunohistochemistry-in-head-and-neck-cancer-how-valid-is-p16ink4a-as-surrogate-marker/#comments</comments>
		<pubDate>Tue, 17 Apr 2012 19:58:24 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV infections]]></category>
		<category><![CDATA[p16]]></category>
		<category><![CDATA[tonsillar SCC]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12848</guid>
		<description><![CDATA[Source: HighWire- Stanford University It has been proposed that p16(INK4A) qualifies as a surrogate marker for viral oncogene activity in head and neck cancer (HNSCC). By analyzing 78 HNSCC we sought to validate the accuracy of p16(INK4A) as a reliable marker of active HPV infections in HNSCC. To this end we determined HPV DNA (HPVD) [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-dna-e6i-mrna-expression-and-p16ink4a-immunohistochemistry-in-head-and-neck-cancer-how-valid-is-p16ink4a-as-surrogate-marker/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>April: Oral Cancer Awareness Month</title>
		<link>http://oralcancernews.org/wp/april-oral-cancer-awareness-month/</link>
		<comments>http://oralcancernews.org/wp/april-oral-cancer-awareness-month/#comments</comments>
		<pubDate>Mon, 02 Apr 2012 16:47:20 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[OCF In The News]]></category>
		<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[alcohol]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oral cancer awareness month]]></category>
		<category><![CDATA[Oropharynx]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>
		<category><![CDATA[The American Cancer Society]]></category>
		<category><![CDATA[The Oral Cancer Foundation]]></category>
		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12733</guid>
		<description><![CDATA[Source: Aspen Dental April is Oral Cancer Awareness Month. According to Brian Hill, founder and executive director of the Oral Cancer Foundation, as many as 40,000 people in the United States will be told they have oral or pharyngeal cancer in 2012. Some of them may be sitting in your dental chair today. With one [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/april-oral-cancer-awareness-month/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Oral Complications After Head/Neck Radiation &#8216;Underreported&#8217;</title>
		<link>http://oralcancernews.org/wp/oral-complications-after-headneck-radiation-underreported/</link>
		<comments>http://oralcancernews.org/wp/oral-complications-after-headneck-radiation-underreported/#comments</comments>
		<pubDate>Mon, 26 Mar 2012 18:58:14 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[City of Hop National Medical Center]]></category>
		<category><![CDATA[dry mouth]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[mucosal sensitivity]]></category>
		<category><![CDATA[oral carcinoma]]></category>
		<category><![CDATA[oral problems]]></category>
		<category><![CDATA[radiation therapy]]></category>
		<category><![CDATA[sticky saliva]]></category>
		<category><![CDATA[Vanderbilt Head and Neck Symptom Survey]]></category>
		<category><![CDATA[xerostomia]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12699</guid>
		<description><![CDATA[Source: Elsevier Global Medical News Late oral effects of head and neck cancer therapy are &#8220;multiple, underreported, and under-appreciated. &#8220;That is the perspective of Joel Epstein, D.M.D., who has worked extensively with head and neck cancer patients experiencing severe dental and other oral problems following radiation therapy. &#8220;The acute complications of head and neck cancer therapy [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/oral-complications-after-headneck-radiation-underreported/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CDC to launch new, graphic anti-smoking campaign</title>
		<link>http://oralcancernews.org/wp/cdc-to-launch-new-graphic-anti-smoking-campaign/</link>
		<comments>http://oralcancernews.org/wp/cdc-to-launch-new-graphic-anti-smoking-campaign/#comments</comments>
		<pubDate>Thu, 15 Mar 2012 17:34:33 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cancerous lesions]]></category>
		<category><![CDATA[CDC]]></category>
		<category><![CDATA[cigarettes]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[tobacco taxes]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12651</guid>
		<description><![CDATA[One of the ads by the Centers for Disease Control shows Shawn Wright who had a tracheotomy after being diagnosed with head and neck cancer. ATLANTA — Tobacco taxes and smoking bans haven’t budged the U.S. smoking rate in years. Now the government is trying to shock smokers into quitting with a graphic nationwide advertising [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/cdc-to-launch-new-graphic-anti-smoking-campaign/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Epidermal Growth Factor Receptor and the Changing Face of Oropharyngeal Cancer</title>
		<link>http://oralcancernews.org/wp/epidermal-growth-factor-receptor-and-the-changing-face-of-oropharyngeal-cancer/</link>
		<comments>http://oralcancernews.org/wp/epidermal-growth-factor-receptor-and-the-changing-face-of-oropharyngeal-cancer/#comments</comments>
		<pubDate>Fri, 09 Mar 2012 17:33:51 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cetuximab]]></category>
		<category><![CDATA[chemoradiotherapy]]></category>
		<category><![CDATA[epidermal growth factor receptor]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>
		<category><![CDATA[Oropharynx]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12620</guid>
		<description><![CDATA[Source: Journal of Clinical Oncology To the Editor: In their article, Chaturvedi et al1 document the rise in human papillomavirus (HPV) –associated cancers as a proportion of squamous cell carcinomas of the oropharynx over the last 25 years. The contemporary figures are mirrored by two recent British studies2,3 demonstrating that the majority of oropharyngeal cancers [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/epidermal-growth-factor-receptor-and-the-changing-face-of-oropharyngeal-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization</title>
		<link>http://oralcancernews.org/wp/evaluation-of-a-combined-triple-method-to-detect-causative-hpv-in-oral-and-oropharyngeal-squamous-cell-carcinomas-p16-immunohistochemistry-consensus-pcr-hpv-dna-and-in-situ-hybridization/</link>
		<comments>http://oralcancernews.org/wp/evaluation-of-a-combined-triple-method-to-detect-causative-hpv-in-oral-and-oropharyngeal-squamous-cell-carcinomas-p16-immunohistochemistry-consensus-pcr-hpv-dna-and-in-situ-hybridization/#comments</comments>
		<pubDate>Thu, 01 Mar 2012 00:24:29 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[Head and neck squamous cell carcinoma]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[molecular detection methods]]></category>
		<category><![CDATA[oral cavity]]></category>
		<category><![CDATA[Oropharynx]]></category>
		<category><![CDATA[p-16-IHC]]></category>
		<category><![CDATA[p16 protein]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12573</guid>
		<description><![CDATA[Source: 7thspace.com Recent emerging evidences identify Human Papillomavirus (HPV) related Head and Neck squamous cell carcinomas (HN-SCCs) as a separate subgroup among Head and Neck Cancers with different epidemiology, histopathological characteristics, therapeutic response to chemo-radiation treatment and clinical outcome. However, there is not a worldwide consensus on the methods to be used in clinical practice. [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/evaluation-of-a-combined-triple-method-to-detect-causative-hpv-in-oral-and-oropharyngeal-squamous-cell-carcinomas-p16-immunohistochemistry-consensus-pcr-hpv-dna-and-in-situ-hybridization/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cancer Patients Who Smoke Report Worse Pain, Symptoms</title>
		<link>http://oralcancernews.org/wp/cancer-patients-who-smoke-report-worse-pain-symptoms-2/</link>
		<comments>http://oralcancernews.org/wp/cancer-patients-who-smoke-report-worse-pain-symptoms-2/#comments</comments>
		<pubDate>Wed, 29 Feb 2012 00:43:34 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cancer patients]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[lung cancer]]></category>
		<category><![CDATA[opioids]]></category>
		<category><![CDATA[smokers]]></category>
		<category><![CDATA[University of Texas MD Anderson Cancer Center]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12570</guid>
		<description><![CDATA[Source: MedScapeToday.com February 24, 2012 (Palm Springs, California) — Cancer patients who smoke experience more severe symptoms than nonsmoking cancer patients and are also at greater risk of misusing opioids, a new study shows. &#8220;Our findings show a profile of higher levels of physical symptoms (pain, fatigue, poor appetite, and insomnia) and psychological symptoms (depression [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/cancer-patients-who-smoke-report-worse-pain-symptoms-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Timing of Post-TX Imaging Key in Head, Neck Cancer</title>
		<link>http://oralcancernews.org/wp/timing-of-post-tx-imaging-key-in-head-neck-cancer/</link>
		<comments>http://oralcancernews.org/wp/timing-of-post-tx-imaging-key-in-head-neck-cancer/#comments</comments>
		<pubDate>Wed, 22 Feb 2012 16:47:08 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemoradiation]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[Head and neck squamous cell carcinoma]]></category>
		<category><![CDATA[PET]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12533</guid>
		<description><![CDATA[Source: MedScape Today Summary The investigators report on a systematic review and meta-analysis of 51 studies involving 2335 patients with head and neck squamous cell carcinoma who underwent post-treatment or surveillance with 18F-fluorodeoxyglucose (FDG) PET or FDG-PET/CT. The random-effects model-weighted mean pooled sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for detection [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/timing-of-post-tx-imaging-key-in-head-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV a gender-neutral killer</title>
		<link>http://oralcancernews.org/wp/hpv-a-gender-neutral-killer/</link>
		<comments>http://oralcancernews.org/wp/hpv-a-gender-neutral-killer/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 17:16:31 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cancerous lesions]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[Journal of Clinical Oncology]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12484</guid>
		<description><![CDATA[Source: DailyPress.com Socially conservative lawmakers will likely repeal Virginia&#8217;s requirement that schoolgirls get vaccinated against a sexually transmitted virus called HPV that can, and now will, kill many of them. They&#8217;re repealing it in the name of sexual abstinence, family values and apple pie. In the name of keeping government out of private health-care decisions [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-a-gender-neutral-killer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Adaptive radiotherapy may benefit patients with head and neck cancer</title>
		<link>http://oralcancernews.org/wp/adaptive-radiotherapy-may-benefit-patients-with-head-and-neck-cancer/</link>
		<comments>http://oralcancernews.org/wp/adaptive-radiotherapy-may-benefit-patients-with-head-and-neck-cancer/#comments</comments>
		<pubDate>Fri, 10 Feb 2012 17:40:11 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[Oropharynx]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>
		<category><![CDATA[The Feinstein Institute for Medical Research]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12447</guid>
		<description><![CDATA[Source: News-Medical.net Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy (ART) for head and neck cancer. The trial, sponsored by the National Cancer Institute, provides evidence that ART may benefit patients [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/adaptive-radiotherapy-may-benefit-patients-with-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Head and neck cancer carries substantial comorbidity burden</title>
		<link>http://oralcancernews.org/wp/head-and-neck-cancer-carries-substantial-comorbidity-burden/</link>
		<comments>http://oralcancernews.org/wp/head-and-neck-cancer-carries-substantial-comorbidity-burden/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 17:16:32 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[comorbidity]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[oral cavity]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12428</guid>
		<description><![CDATA[Source: MedWire News People with head and neck cancer experience a high burden of both acute and chronic comorbidity, shows an analysis of a large Dutch population-based cohort. The researchers therefore advise clinicians to account for patients&#8217; comorbidity burden when assessing the risk-benefit profile for different treatment options. Sarah Landis (GlaxoSmithKline, London, UK) and co-workers [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/head-and-neck-cancer-carries-substantial-comorbidity-burden/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Newer radiation technology improves head and neck cancer patients&#8217; long-term quality of life</title>
		<link>http://oralcancernews.org/wp/newer-radiation-technology-improves-head-and-neck-cancer-patients-long-term-quality-of-life/</link>
		<comments>http://oralcancernews.org/wp/newer-radiation-technology-improves-head-and-neck-cancer-patients-long-term-quality-of-life/#comments</comments>
		<pubDate>Fri, 27 Jan 2012 18:28:22 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[American Head and Neck Society]]></category>
		<category><![CDATA[American Society for Radiation Oncology]]></category>
		<category><![CDATA[American Society of clinical oncology]]></category>
		<category><![CDATA[dry mouth]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[IMRT]]></category>
		<category><![CDATA[Multidisciplinary Head and Neck Cancer Symposium]]></category>
		<category><![CDATA[radiation therapy]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12375</guid>
		<description><![CDATA[Source: Eurekalert.org Patients treated with IMRT for head and neck cancer report an increasingly better quality of life post-treatment when compared to patients receiving other forms of radiation therapy, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM. Intensity modulated radiation therapy, or IMRT, [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/newer-radiation-technology-improves-head-and-neck-cancer-patients-long-term-quality-of-life/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

